Bird & Bird advises Pathos Communications plc on its AIM IPO

International law firm Bird & Bird has advised Pathos Communications plc ("Pathos"), the technology-enabled, human-led PR company, on its admission to trading on the AIM Market of the London Stock Exchange.

Pathos aims to democratise small-medium enterprises’ access to established news publications utilising a “pay-on-results” model. Pathos collaborates with its clients to create and distribute articles across a variety of platforms including established news outlets, digital media and podcast channels, leveraging its proprietary AI-driven technologies, which are currently validated, functional internal assistants at minimum viable product stage. 

Admission follows the successful closure of a fundraising of £5.6 million through a placing of new and existing Ordinary Shares with certain institutional and other investors. Upon admission today, the company has a market capitalisation of approximately £20 million.

The international Bird & Bird team across the London and Dubai offices was led by partner Clive Hopewell (Corporate, London) and associate Zoe Bannell-Symes (Corporate, London), and partner Surabhi Singhi (Corporate, Dubai), associate Maria John (Corporate, Dubai) and associate Omar Sharief (Corporate, Dubai).

Clive Hopewell, head of international Equity Capital Markets at Bird & Bird, commented: "We are pleased to have advised Pathos on its successful AIM IPO, marking a significant milestone in its growth journey. The London markets provide the perfect platform for such an international media business, and we wish all the team at Pathos continued success."

Omar Hamdi, Founder and CEO of Pathos commented: "Bird & Bird's team are good communicators as well as incredible lawyers. They understand the inherent unpredictability of an IPO process and embrace it, never losing sight of the goal. They have been a reassuring presence throughout the process."

News & Deals

More News & Deals
Deal Bird & Bird advises ASX-listed Flight Centre Travel Group on its acquisition of Iglu

Dec 17 2025

Read More
Deal Bird & Bird advises Orphalan on the acquisition of Orphelia Pharma

Dec 16 2025

Read More
Deal Bird & Bird ATMD advises SuperX on Strategic Investment in NVIDIA Solution Provider MicroInference

Dec 15 2025

Read More
Deal Bird & Bird advises OSL on acquisition by Terma A/S to create leading counter-drone security platform

Dec 11 2025

Read More
Deal Bird & Bird advises Cheyne Capital on the acquisition of two Buxton Hotels with Champneys

Dec 10 2025

Read More
Deal Bird & Bird advises AFYREN on a €23m capital increase

Dec 09 2025

Read More